Improved survival in patients with end-stage cancer treated with coenzyme Q10 and other antioxidants: A pilot study

Journal of International Medical Research

Volumn 37, Issue 6, 2009, Pages 1961-1971

  Hertz, Niels ^a   Lister, R E ^b  

^a London Metropolitan University ^*  (Denmark)

^b LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Antioxidants; End stage cancer; Survival

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CYANOCOBALAMIN; FISH OIL; FOLIC ACID; GAMMA LINOLENIC ACID; NICOTINIC ACID; PANTOTHENIC ACID; PYRIDOXINE; RETINOL; RIBOFLAVIN; SELENOMETHIONINE; THIAMINE; UBIDECARENONE;

ADULT; ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; COLON CANCER; DEATH; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; LUNG CANCER; MALE; NEOPLASM; OBSERVATIONAL STUDY; OVARY CANCER; PANCREAS CANCER; PILOT STUDY; PREDICTION; PROSTATE CANCER; SKIN CANCER; STOMACH CANCER; SUPPLEMENTATION; SURVIVAL TIME; TERMINAL CARE;

EID: 74949125991     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700634     Document Type: Article

References (54)

1. The Alpha-tocopherol Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-1035.
2. Omenn GS, Goodman GE, Thornquist MD, et al: Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-1155.
3. Hennekens CH, Buring JE, Manson JE, et al: Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-1149.
4. Cole WC, Prasad K: Contrasting effects of vitamins as modulators of apoptosis in cancer cells and normal cells: a review. Nutr Cancer 1997; 29: 97-103.
5. Liu M, Pelling JC, Ju J, et al: Antioxidant action via p53-mediated apoptosis. Cancer Res 1998; 58: 1723-1729.
6. Iwasaki K, Koyama N, Nogaki A, et al: Role of hydrogen peroxide in cytotoxicity induction by ascorbates and other redox compounds. Anticancer Res 1998; 18: 4333-4337.
7. Dreher D, Junod AF: Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32A: 30-38.
8. Gerster H: β-Carotene, vitamin E and vitamin C in different stages of experimental carcinogenesis. Eur J Clin Nutr 1995; 49: 155-168.
9. Shklar G, Schwartz JL: Vitamin E inhibits experimental carcinogenesis and tumor angiogenesis. Eur J Cancer B Oral Oncol 1996; 32B: 114-119.
10. Zheng W, Sellers TA, Doyle TJ, et al: Retinol, antioxidant vitamins, and cancers of the upper digestive tract in a prospective cohort of postmenopausal women. Am J Epidemiol 1995; 142: 955-960.
11. Bostick RM, Potter JD, McKenzie DR, et al: Reduced risk of colon cancer with high intake of vitamin E: The Iowa Women's Health Study. Cancer Res 1993; 53: 4230-4237.
12. Woodson K, Tangrea JA, Barrett MJ, et al: Serum α-tocopherol and subsequent risk of lung cancer among male smokers. J Natl Cancer Inst 1999; 91: 1738-1745.
13. Hercberg S, Galan P, Preziosi P, et al: The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004; 164: 2335-2342. Erratum in Arch Intern Med 2005; 165: 286.
14. Clark LC, Combs GF, Turnbull BW, et al: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996; 276: 1957-1963. Erratum in JAMA 1997; 277: 1520.
15. Clark LC, Dalkin B, Krongrad A, et al: Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 1998; 81: 730-734.
16. Rougereau A, Sallerin T, Chapet J, et al: Adjuvant treatment of patients with neoplastic lesions using the combination of a vitamin complex and an amino acid. Apropos of a series of 17 cases of epidermoid carcinoma of the upper aerodigestive tract. Ann Gastroenterol Hepatol (Paris) 1993; 29: 99-102 [in French].
17. Kaugars GE, Silverman S, Lovas JG, et al: A clinical trial of antioxidant supplements in the treatment of oral leukoplakia. Oral Surg Oral Med Oral Pathol 1994; 78: 462-468.
18. Prasad KN, Kumar R: Effect of individual and multiple antioxidant vitamins on growth and morphology of human nontumorigenic and tumorigenic parotid acinar cells in culture. Nutr Cancer 1996; 26: 11-19.
19. Blot WJ, LI J-Y, Taylor PR, et al: Nutrition intervention trials in China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85: 1483-1492.
20. Shklar G, Schwartz J, Trickler D, et al: The effectiveness of a mixture of β-carotene, α-tocopherol, glutathione, and ascorbic acid for cancer prevention. Nutr Cancer 1993; 20: 145-151.
21. Waris G, Ahsan H: Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006; 5: 14.
22. Lamm DL, Riggs DR, Shriver JS, et al: Megadose vitamins in bladder cancer: a double-blind clinical study. J Urol 1994; 151: 21-26.
23. Carstensen B, Storm H, Schou G (eds): Survival of Danish cancer patients 1943-1987. APMIS Suppl 1993; 33: 1-213.
24. Ewers M: Survival of Danish cancer patients 1943-1987. Breast. APMIS Suppl 1993; 33: 99-106.
25. Gawne-Cain ML, Malthouse SR, Reidy JF, et al: Radiographic patterns of intrathoracic disease in breast carcinoma: prognostic implications. Clin Radiol 1993; 48: 253-257.
26. Banerjee AK, Willetts I, Robertson JF, et al: Pleural effusion in breast cancer: a review of the Nottingham experience. Eur J Surg Oncol 1994; 20: 33-36.
27. Clark GM, Sledge GW, Osborne CK, et al: Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 1987; 5: 55-61.
28. Blanco G, Holli K, Heikkinen M, et al: Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. Br J Cancer 1990; 62: 142-146.
29. Koenders PG, Beex LV, Kloppenborg PW, et al: Human breast cancer: survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res Treat 1992; 21: 173-180.
30. Sampson JH, Carter JH, Friedmann AH, et al: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998; 88: 11-20.
31. Schoeggl A, Kitz K, Ertl A, et al: Prognostic factor analysis for multiple brain metastases after gamma knife radiosurgery: results in 97 patients. J Neurooncol 1999; 42: 169-175.
32. Sundström JT, Minn H, Lertola KK, et al: Prognosis of patients treated for intracranial metastases with whole-brain irradiation. Ann Med 1998; 30: 296-299.
33. Lagerwaard FJ, Levendag PC, Nowak PJ, et al: Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Phys 1999; 43: 795-803.
34. Henson D, Ries LA, Carriaga MT: Conditional survival of 56,268 patients with breast cancer. Cancer 1995; 76: 237-242.
35. Hansen J, Olsen JH: Survival of Danish cancer patients 1943-1987. Respiratory system. APMIS Suppl 1993; 33: 77-98.
36. Johansen C, Soll-Johanning H, Kolstad H, et al: Survival of Danish cancer patients 1943-1987. Digestive organs. APMIS Suppl 1993; 33: 35-76.
37. Midgley R, Kerr D: Colorectal cancer. Seminar. Lancet 1999; 353: 391-399.
38. Grothey A, Sargent D, Goldberg RM, et al: Survival of patients with advanced colorectal cancer improves with the availability of fluoruracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004; 22: 1209-1214.
39. Bandealy MT, Gonin R, Loehrer PJ, et al: Prospective randomized trial of 5-fluoruracil versus 5-fluoruracil plus levamisol in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial. Clin Cancer Res 1998; 4: 935-939.
40. Hvidt V: Renal tumours. In: Compendium of Surgery (Hald T, Stadil F, eds.). Copenhagen: Nyt Nordisk Forlag Arnold Busk, 1996; pp 1422-1433 [in Danish].
41. Tjønneland A, Skov T, Mellemgaard A: Survival of Danish cancer patients 1943-1987. Urinary tract. APMIS Suppl 1993; 33: 137-148.
42. Jubelirer SJ: A review of the treatment and survival rates of 138 patients with glioblastoma multiforme. W V Med J 1996; 92: 186-190.
43. Kreth FW, Berlis A, Spiropoulou V, et al: The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 1999; 86: 2117-2123.
44. Sagar SM, Israel MA: Primary and metastatic tumours of the nervous system. In: Harrison's Principles of Internal Medicine 17th edn (Fauci A, Braunwald E, Kasper DL, et al, eds). New York: McGraw-Hill, 2008; p 2604.
45. Møller H, Friis S, Kjær SK: Survival of Danish cancer patients 1943-1987. Male genital organs. APMIS Suppl 1993; 33: 122-136.
46. Kjaer SK, Storm HH: Survival of Danish cancer patients 1943-1987. Female genital organs. APMIS Suppl 1993; 33: 107-121.
47. Østerlind A, Kjems E: Malignant melanoma of the skin. APMIS Suppl 1993; 33: 149-155.
48. Miller DR, Andersson GT, Stark JJ, et al: Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998; 16: 3649-3655.
49. Shklar G: Mechanisms of cancer inhibition by anti-oxidant nutrients. Oral Oncol 1998; 34: 24-29.
50. Rayman MP: Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 2005; 64: 527-542.
51. 10 on the status of lipid peroxidation and antioxidants in DMBA induced breast cancer. Mol Cell Biochem 2005; 273: 151-160.
52. 10 supplementation to breast cancer patients undergoing Tamoxifen therapy. Biofactors 2008; 32: 151-159.
53. Nakopoulou L, Tsirmpa I, Alexandrou P, et al: MMP-2 protein in invasive breast cancer and the impact of MMP-TIMP-2 phenotype on overall survival. Breast Cancer Res Treat 2003; 77: 145-155.
54. Nillson UW, Garvin S, Dabrosin C: MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells. Breast Cancer Res Treat 2007; 102: 253-261.